Blog

Nuclear fusion has long held the promise of cheap, plentiful and, above all, clean energy with zero carbon emissions and minimal radiation issues that undermine public confidence in nuclear fission. The UK has been at the forefront of fusion research, hosting the Joint European Torus (JET) at the UK Atomic Energy Authority’s (UKAEA) site at […]

read more

Synbio Digest features news, views and reports covering the synthetic biology industry and recent research. 5th November 2018 Headlines: Budget risks reducing company R&D tax credits whilst increasing govt R&D spend. Blue bugs. Budget 2018. Chancellor Philip Hammond announced increases to R&D spending and commitment to investing 2.4% of GDP in R&D by 2027. The […]

read more

UKI2S announced in August the successful exit of its portfolio company Quethera. Acquired by Japanese pharma giant Astellas for up to £85 million, the deal sees Quethera’s novel ophthalmic treatment program continue under the new parent. How did this successful exit come about in under three years since first raising funds? Quethera was founded by […]

read more

1 2 3 4 5 25